Nina Kjellson

Directeur/Membre du Conseil chez ELOXX PHARMACEUTICALS, INC. Fortune : - $ au 30/09/2026

Profil

Ms. Nina S.
Kjellson is an Independent Director at Eloxx Pharmaceuticals, Inc., a Partner at Pelican Advisors LLC, a Director at CinRx Pharma LLC, a Chairman at Essential Access Health, a General Partner at Canaan Management, Inc., a Co-Chairman at ConsumerMed.Org, a Managing Member at Canaan Partners X LLC, a Managing Member at Canaan Partners XI LLC, a Managing Member at Canaan Partners XII LLC and a Venture Member at InterWest Management Partners IX LLC.
She is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Actio Biosciences, Inc., Proxygen Co., Rondo Therapeutics, Inc., Trishula Therapeutics, Inc., Dauntless Pharmaceuticals, Inc., Tizona Therapeutics, Inc., WellTok, Inc., Girl Effect, Intrepida Bio, Inc., Life Science Cares, Inc., Predilytics, Inc. and Primera Diagnostics, Inc. Ms. Kjellson was previously employed as an Independent Director by Panacea Acquisition Corp.
II, an Independent Director by Tyra Biosciences, Inc., an Independent Director by Eiger BioPharmaceuticals, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by OCERA Therapeutics LLC, an Independent Director by Trius Therapeutics, Inc., a Consultant by InterWest Venture Management Co., an Investment Manager by Bay City Capital LLC, a Research Associate by Oracle Partners LP, a Principal by The Henry J.
Kaiser Family Foundation, and a Non-Executive Director by Cebix, Inc. She also served on the board at Sardona Therapeutics, Inc., PACT Pharma, Inc., Vineti, Inc., NovaCardia, Inc., Alt12 Apps, Inc., Alvine Pharmaceuticals, Inc., Annum Health, Inc., CNS Therapeutics, Inc., Eiger BioPharmaceuticals, Inc. /Old/, Kanisa Pharmaceuticals, Inc., Labrys Biologics, Inc., Lycera Corp., MacuSight, Inc., Nereus Pharmaceuticals, Inc., Ocera Therapeutics, Inc. /Old/, PrimeraDx, Inc., Sequel Pharmaceuticals, Inc. and Xenon Pharmaceuticals, Inc. She received her undergraduate degree from Stanford University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ELOXX PHARMACEUTICALS, INC. -.--%	08/06/2026	0 ( -.--% )	- $	30/09/2026

Postes actifs de Nina Kjellson

Sociétés	Poste	Début
ELOXX PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	27/05/2026
Intrepida Bio, Inc.	Directeur/Membre du Conseil	-
Canaan Management, Inc.	Private Equity Investor	01/09/2015
Essential Access Health	Président	01/01/2016
Canaan Partners XI LLC	Corporate Officer/Principal	-
Canaan Partners X LLC	Corporate Officer/Principal	-
Rondo Therapeutics, Inc.	Directeur/Membre du Conseil	01/02/2022
Life Science Cares, Inc.	Directeur/Membre du Conseil	-
Girl Effect	Directeur/Membre du Conseil	-
░░░░░░ ░░░░░░░░ ░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░ ░░░░░░ ░░░	░░░░░░░░░░░░░░░░░░░░░ ░░ ░░░░ ░░░░░░	░░░░░░░░░░

Anciens postes connus de Nina Kjellson

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░